Sonavex

Sonavex

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://sonavex.com/

Last Round

Series A

Extension

Oct 24, 2024

Total Funding Raised

$27.15M

Company Overview

Sonavex is a medical device company that develops automated 3D ultrasound solutions designed to provide quantitative blood flow and vascular data at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

automated 3D ultrasoundmedical deviceAI-powered ultrasoundpoint of care ultrasoundPOCUSMedTechblood flow measurementmedical AIAV fistula maturationvascular accessbioresorbable implantultrasound markercannulation guidancemedical imagingpost-surgical monitoringFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sonavex Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sonavex Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 24, 2024
VC RoundOct 24, 2024
GrantSep 25, 2024
GrantMay 25, 2022
VC RoundNov 5, 2019
Grant
Aug 29, 2019

Key People

Founding team and executive leadership

David Narrow

CEO

Executive Team

Sonavex Investors

Notable investors and investment history

InvestorRounds
Grey Sky Venture PartnersSeries A
GenHenn CapitalSeries A Extension
Fusion FundSeries A
JSTAR Capital InvestmentsSeries A Extension
Abell FoundationSeries A
NIH RADxGrant
TEDCOConvertible Debt, Series A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2025

    Monthly visitors grew 71% MoM, reaching 2.4K.

  • Oct 29, 2024

    Monthly visitors increased 36% MoM.

Sonavex Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sonavex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sonavex's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range24
Year Founded2013
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.